NasdaqCM:CPRXBiotechs
Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Renewed Interest And Pocket Pivot Signal
Renewed interest in Catalyst Pharmaceuticals stock
Renewed interest in Catalyst Pharmaceuticals (CPRX) stock has been driven by a mix of fundamental and technical factors, including recent revenue and earnings growth, high profitability, a debt free balance sheet, and a fresh Pocket Pivot signal.
See our latest analysis for Catalyst Pharmaceuticals.
At a share price of $24.45, Catalyst Pharmaceuticals has seen a 7.61% 1 month share price return and a 5.62% year to date share price return,...